Sleep-disordered breathing
Sleep apnea is common, mostly undiagnosed, and in its severe form is linked to roughly double the risk of dying early. Treatment reliably makes you less sleepy and lowers blood pressure; whether it also prevents heart attacks and strokes is still being argued over, and the viral fix of taping your mouth shut can make some people worse.
If you snore loudly, wake unrefreshed, or someone has seen you stop breathing in your sleep, take the free eight-question STOP-Bang screener — three or more "yes" answers means ask for a sleep study, which for most adults is done at home. If you have moderate or severe apnea, a CPAP machine used at least 4 hours a night on at least 70% of nights is the first-line treatment, with weight loss, a dentist-fitted mouthpiece or side-sleeping as the main alternatives. Don't tape your mouth until a clinician has checked your nose.
A common condition that hides behind "I'm just tired"
Obstructive sleep apnea (OSA) is the repeated partial or complete collapse of the upper airway during sleep. When the muscles holding the tongue base, soft palate and throat walls open relax, the airway falls in; blood oxygen drops, the stress response surges, and the sleeper half-wakes without remembering it. People with severe apnea can do this 30 or more times an hour.
A global analysis estimated that 936 million adults aged 30–69 have mild-to-severe OSA, 425 million of them moderate-to-severe.[1] It was funded by the sleep-apnea device maker ResMed, so treat the exact figures with caution, though the direction isn't in doubt. Most cases are undiagnosed.
Severity is graded by the apnea-hypopnea index (AHI), the average number of full or partial airway blockages per hour of sleep: under 5 is normal, 5–14 mild, 15–29 moderate, 30 or more severe. It is a blunt measure: it counts events without weighing how deep they are. In an observational study of adults with coronary disease, the total overnight oxygen shortfall, the "hypoxic burden", predicted cardiovascular events (about 87% more in the worst third), while an AHI of 30 or more did not, in a study supported by the ResMed Foundation.[2] A larger cohort agreed: hypoxic burden and time spent below 90% oxygen were the only sleep-study measures that tracked cardiovascular events.[3]
How much risk, and for whom
The danger is concentrated in severe apnea. Pooling 27 cohort studies covering over 3 million people, severe OSA was linked to roughly double the death rate from any cause and nearly triple the death rate from heart disease.[4] Mild and moderate apnea, in the same analysis, were not significantly linked to death.
A second pooling of 18 cohorts, over 25,000 people followed for a median of 9 years, found the same staircase for new cardiovascular disease: about 56% higher risk with moderate apnea and about 145% higher with severe, with the mild-apnea estimate again not significant.[5] People using CPAP at least 4 hours a night had about 24% lower risk — an observational finding, but pointing the same way as the trial data below.
Stroke has an older, durable signal. In about 1,000 patients who had a sleep study, apnea (an AHI of 5 or more) was linked to roughly double the risk of stroke or death, after adjusting for age, sex, smoking, weight, diabetes, blood pressure and atrial fibrillation.[6]
The dementia signal is real but smaller: about 33% higher risk of dementia and 45% higher risk of Alzheimer's disease, with no clear link to vascular dementia.[7] Obesity and age drive both, so this is one more reason to treat apnea, not proof that it causes dementia.
What it is doing in the body. The damage comes less from the collapse than from years of hundreds of nightly cycles of oxygen dropping and rushing back. That floods tissues with oxidative damage, keeps a low-grade inflammation switched on (see chronic inflammation) and stiffens arteries — and apnea is present in most people whose high blood pressure resists medication, one of its commonest treatable contributors. The pathway is well described; how much of the risk it explains, against obesity and age, is less certain.
Who should get tested, and how
Risk factors: being male (though women are markedly underdiagnosed, and catch up after menopause); a body mass index (BMI) of 30 or more; a neck over 43 cm in men or 40 cm in women; a small or recessed jaw, narrow palate or large tongue; a family history; alcohol or sedatives near bedtime; and hypothyroidism, acromegaly or polycystic ovary syndrome.
Symptoms — any one is worth a workup: loud habitual snoring; a partner reporting gasping, choking or pauses (the most specific sign); unrefreshing sleep or dozing at the wheel; blood pressure poorly controlled on three or more drugs; atrial fibrillation; morning headaches; erectile dysfunction; getting up several times a night to urinate.
The STOP-Bang screener asks eight yes/no questions: do you Snore loudly, feel Tired in the day, has anyone Observed you stop breathing, do you have high blood Pressure; is your BMI over 35, your Age over 50, your Neck over 40 cm, your Gender male? Three or more "yes" answers flags high risk.[8] In the general population it picks up about 88% of moderate-to-severe apnea and 92% of severe apnea, but nearly three in five people who don't have apnea also score positive, so a positive score means "get tested", not "you have apnea".[9]
A home sleep test is now first-line for most adults without major other illness; a full in-lab study is for complex cases, suspected central apnea or an inconclusive home test. Home tests can underestimate severity, so a negative result in someone with strong symptoms should lead to a lab study, not reassurance — a strong recommendation in the US sleep-medicine guideline.[10] Severity also varies from night to night: among 67,278 adults monitored at home for months, about one in five diagnosed from a single night were misclassified.[11]
This is case-finding, not mass screening. The US Preventive Services Task Force rates the evidence for screening adults without symptoms as insufficient, and no trial has shown it improves health.[12] Testing someone with symptoms or stubborn high blood pressure is different, and sound.
CPAP: what it reliably does, and what's still open
Continuous positive airway pressure (CPAP), a small pump blowing air through a mask to splint the airway open, is first-line for moderate-to-severe OSA.[13]
Adherence decides everything: at least 4 hours a night on at least 70% of nights, which a substantial minority struggle with at first. Self-adjusting machines, a better-fitting mask, heated humidification and proper follow-up all help; if the first setup fails, the answer is usually a different mask, not giving up.
What it reliably does. In randomised trials, CPAP used properly cuts daytime sleepiness by about 2.4 points on the 24-point Epworth sleepiness scale — only about 1 point in people who weren't sleepy to begin with. It lowers 24-hour blood pressure modestly in typical patients, by roughly 1.5 mmHg systolic, but by about 6 mmHg in people whose high blood pressure resists medication.[14][15] Car-crash rates fall too, though only in before-and-after comparisons, a design that flatters the result.
What it doesn't do. It did not stop atrial fibrillation returning after ablation in the randomised trial that tested it — 57% recurrence in both groups.[16] And it doesn't help you lose weight: across 39 randomised trials, BMI rose very slightly on CPAP, about 0.15 kg/m², confined to people using it under five hours a night.[17]
Heart attacks and strokes: genuinely unresolved. The largest trial randomised 2,717 adults with moderate-to-severe apnea and existing cardiovascular disease to CPAP or usual care. Over about 3.7 years, cardiovascular events were no lower (17.0% against 15.4%, well within chance), though snoring, sleepiness, mood and quality of life all improved.[18] Two things limit that null: average use was only 3.3 hours a night, below the 4-hour threshold, and participants were chosen for being not very sleepy.
Pooling the randomised trials, everyone assigned to CPAP still showed no benefit, while people actually using it 4 or more hours a night had about 31% fewer cardiovascular events.[19] But that comparison isn't randomised: people who stick with treatment differ from those who don't in ways that predict better health on their own. A 2026 analysis across three trials found benefit concentrated in people whose oxygen drops deeply rather than often — but those cut-offs were drawn from inside the trials and never tested elsewhere, and the work was part-funded by ResMed.[20] So the open question is not whether CPAP protects the heart in everyone, but in whom.
Not all apnea is obstructive. In central sleep apnea the airway stays open and the brain stops sending the signal to breathe; it can look similar on a home test but is treated differently. A device called adaptive servo-ventilation, sometimes offered for central apnea, was tested in 1,325 people with heart failure and a weak heart pump: it didn't reduce cardiovascular events and increased death from any cause by about 28%.[21] A later trial with a different design didn't reproduce the harm.[22] Either way it is not interchangeable with CPAP, and anyone with heart failure and mainly central events needs a sleep physician.
If CPAP doesn't work for you
Most alternatives also cut apnea events, though less than CPAP does when it is actually used.
| Option | Best for | Effect and caveats |
|---|---|---|
| Weight loss | Apnea driven by obesity | In a cohort of 690 adults, losing 10% of body weight predicted a 26% fall in AHI, and gaining 10% a 32% rise[23] |
| Tirzepatide (a GLP-1-class drug) | Adults with obesity | About 20 fewer events an hour without CPAP and 24 fewer with it, over a year — see GLP-1 receptor agonists[24] |
| Mandibular advancement device | Mild-to-moderate apnea, recessed jaw | A mouthpiece that pulls the lower jaw forward; about 11 fewer events an hour than a dummy device[25]. Dentist-fitted beat off-the-shelf in a small trial,[26] and guidelines prefer it[27] |
| Positional therapy | Events mostly on your back | A device (or a tennis ball in a pyjama pocket) that keeps you off your back; about 7 fewer events an hour than an inactive control[28] |
| Hypoglossal nerve stimulation | Moderate-to-severe apnea, can't tolerate CPAP, right anatomy | An implant that tightens the tongue muscle on each breath; see below |
| Surgery | Selected cases | Multilevel airway surgery has randomised support; removing soft-palate tissue alone is hit-and-miss; jaw-advancement surgery works better but is invasive. Needs an ear-nose-throat specialist |
| Mouth-and-tongue exercises | Add-on for mild-to-moderate apnea | Helps symptoms; on the best randomised evidence, no clear effect on apnea severity — see below |
| AD109 (a pill) | Not yet a general option | The first drug developed specifically for OSA passed a phase 3 trial but cut only about 4 events an hour, a fifth of tirzepatide's effect, with no gain in fatigue; one in five patients stopped because of side effects[29] |
Mouthpieces against CPAP. CPAP beats a mouthpiece by roughly 8 events an hour, but people wear the mouthpiece about 42 minutes a night longer,[30] and in a head-to-head trial whose senior author holds a ResMed-endowed chair, its effect on 24-hour blood pressure was no worse than CPAP's.[31]
Lifestyle beats expectations. In a small trial, an 8-week diet, exercise and sleep-habits programme on top of CPAP produced about 24 fewer events an hour than CPAP alone, still there at six months, with 7 kg of weight loss — rivalling tirzepatide. It was single-centre, unblinded, and enrolled 89 men and no women.[32]
The nerve stimulator. Its famous 68% median AHI drop came from a 126-patient study with no control group, funded by the manufacturer.[33] Switching stimulation off at random in responders was more telling: AHI 7.6 with it on, 25.8 off. And in a randomised trial of a similar implant where the control group got it switched off, 58% responded on active stimulation against 14% with it inactive — response meaning the AHI at least halved and fell below 20.[34]
Surgery. In people who had already failed conventional treatment, multilevel airway surgery beat medical management by about 18 events an hour and nearly 7 sleepiness points — though the authors call the result preliminary.[35]
Mouth taping and nasal breathing: right idea, wrong tool
Nasal breathing has real physiology behind it. Mouth breathing drops the jaw and lets the tongue and soft palate fall back, making collapse more likely. The sinuses also make nitric oxide, a gas that widens blood vessels: air leaving the nose carries about 56 parts per billion, against 14 from the mouth.[36] Measured gains in blood oxygen are short-term and come from a handful of patients,[37] and no trial links habitual nasal breathing to long-term health.
Mouth taping is the weak part. A systematic review found just 10 studies with 213 patients, only two of them showing a significant improvement in apnea measures, and warned of a potentially serious risk of harm: several studies flagged suffocation when the nose is blocked, and many excluded anyone with nasal obstruction — the people most likely to be harmed.[38] No randomised trial of taping for apnea has reported, and no professional body has issued a graded guideline.
Why it can backfire. In 54 apnea patients examined under sedation, closing the mouth improved airflow overall — but made it worse in heavy mouth-breathers and in those blocked at the soft palate. For them the mouth is not a bad habit; it is the bypass around a blocked nose or soft palate.[39]
One legitimate use, under clinical supervision: CPAP users on a nasal mask who leak air through the mouth, where a randomised crossover trial found tape added about 52 minutes of CPAP use a night.[40]
If you breathe through your mouth at night, fix the cause first: an ear-nose-throat check for a deviated septum, polyps or chronic rhinitis, apnea screening, and treatment of any allergic rhinitis with a steroid nasal spray or antihistamines. Side-sleeping (if events cluster on your back) and mouth-and-tongue exercises (if the cause is muscular) come next; tape only after all that, on a clinician's advice.
Myofunctional therapy — daily mouth-and-tongue exercises that retrain the tongue, lips and throat muscles to rest correctly — is often credited with halving apnea severity, a figure from nine small, mostly uncontrolled studies.[41] Restricted to 15 randomised trials, the effect on apnea severity was indistinguishable from none (a re-analysis of mostly low-quality reviews was more positive[42]), while sleepiness improved by about 3.5 Epworth points and sleep quality by about 2.[43] A low-risk add-on that may help CPAP tolerance, not a substitute for it.
What's overrated
- Apps and watches instead of a sleep study. Machine analysis of breathing sounds reaches about 90% sensitivity in research settings,[44] but the cleared smartwatch alert catches only about 43% of moderate apnea (89% of severe). A silent watch is not a negative test.
- Sleeping pills for snoring. They don't treat apnea; they mask the tiredness that would send you for a test. Across 27 randomised trials, prescription hypnotics, z-drugs included, made sleepers slightly harder to rouse but left apnea severity essentially unchanged[45] — alcohol and opioids, which were not covered, do relax the airway. Where insomnia and apnea coexist, treat the insomnia with behavioural therapy first — see insomnia treatment.
- Overnight oxygen instead of CPAP. In a three-way randomised trial, CPAP lowered 24-hour blood pressure and oxygen did no better than nothing.[46] Oxygen fixes the dip but leaves the collapse and the half-waking.
- CBD, magnesium, melatonin or single-nostril breathing for apnea. The supplements may help general sleep (see sleep supplements) and the breathing technique may help relaxation while awake; none touches airway collapse.
- Treating mild apnea as if it carried severe apnea's risk. Treat its symptoms if they bother you; mortality is not the reason.
What to actually do
- Screen, then test: a STOP-Bang of 3+ or a partner reporting pauses means a sleep study.
- On CPAP, change masks rather than quit.
- Lose weight if obesity drives it, and sleep on your side if events cluster on your back.
- Keep the last drink well away from bedtime, and never within three hours of bed — it relaxes the airway and worsens events. See alcohol.
- With heart failure and central apnea, see a sleep physician before accepting any pressure device.
Further reading
- Benjafield AV et al. Estimation of the global prevalence and burden of obstructive sleep apnoea — literature-based analysis. Lancet Respir Med 2019.[47]
- Fu Y et al. Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment. Sleep Breath 2017.[48]
- Chen L et al. Validation of the STOP-Bang questionnaire for screening of obstructive sleep apnea in the general population and commercial drivers: a systematic review and meta-analysis. Sleep Breath 2021.[49]
- Kapur VK et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea. J Clin Sleep Med 2017.[50]
- Patil SP et al. Treatment of Adult OSA With Positive Airway Pressure — AASM Clinical Practice Guideline. J Clin Sleep Med 2019.[51]
- McEvoy RD et al. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea (SAVE). NEJM 2016.[52]
- Sánchez-de-la-Torre M et al. Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis. JAMA 2023.[53]
- Cowie MR et al. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure (SERVE-HF). NEJM 2015.[54]
- Malhotra A et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA). NEJM 2024.[55]
- Carneiro-Barrera A et al. Effect of an Interdisciplinary Weight Loss and Lifestyle Intervention on Obstructive Sleep Apnea Severity: The INTERAPNEA Randomized Clinical Trial. JAMA Netw Open 2022.[56]
- Malhotra A et al. Proximal Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea in the OSPREY Study: A Randomized Controlled Trial. Ann Intern Med 2026.[57]
- Rhee J et al. Breaking social media fads and uncovering the safety and efficacy of mouth taping in patients with mouth breathing, sleep disordered breathing, or obstructive sleep apnea — a systematic review. PLoS One 2025.[58]
- Yang H et al. Mouth Closure and Airflow in Patients With Obstructive Sleep Apnea — a nonrandomized clinical trial. JAMA Otolaryngol Head Neck Surg 2024.[59]
- Gottlieb DJ et al. CPAP versus Oxygen in Obstructive Sleep Apnea (HeartBEAT). NEJM 2014.[60]
- Messineo L et al. Hypnotics on Obstructive Sleep Apnea Severity and Endotypes: A Systematic Review and Meta-Analysis. Am J Respir Crit Care Med 2024.[61]